Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Daisuke Watanabe, Takahiro Kimura, Akemi Yamashita, Tadaaki Minowa, Kunihisa Miura & Akio Mizushima. (2020) The influence of androgen deprivation therapy on hip geometric properties and bone mineral density in Japanese men with prostate cancer and its relationship with the visceral fat accumulation. The Aging Male 23:5, pages 1158-1164.
Read now
Read now
Yasin Ceylan, Bulent Gunlusoy, Asli Koskderelioglu, Muhtesem Gedizlioglu & Tansu Degirmenci. (2020) The depressive effects of androgen deprivation therapy in locally advanced or metastatic prostate cancer: a comparative study. The Aging Male 23:5, pages 733-739.
Read now
Read now
M. F. Duarte, C. Luis, P. Baylina, M. I. Faria, R. Fernandes & J. M. La Fuente. (2019) Clinical and metabolic implications of obesity in prostate cancer: is testosterone a missing link?. The Aging Male 22:4, pages 228-240.
Read now
Read now
Safa Ali Ahmed Amar, Recep Eryilmaz, Halit Demir, Serdar Aykan & Canan Demir. (2019) Determination of oxidative stress levels and some antioxidant enzyme activities in prostate cancer. The Aging Male 22:3, pages 198-206.
Read now
Read now
Karli Sreenivasulu, Hanumanthappa Nandeesha, Lalgudi Narayanan Dorairajan, Medha Rajappa, Vickneshwaran Vinayagam & Cleetus Cherupanakkal. (2018) Gene expression of insulin receptor, insulin-like growth factor increases and insulin-like growth factor-binding protein-3 reduces with increase in prostate size in benign prostatic hyperplasia. The Aging Male 21:2, pages 138-144.
Read now
Read now
Jae Hyun Ryu, Sang Jin Kim, Yun Beom Kim, Tae Young Jung, Woo Jin Ko, Sun Il Kim, Duk Yoon Kim, Tae Hee Oh, Kyong Tae Moon, Hee Ju Cho, Jeong Man Cho & Tag Keun Yoo. (2018) Radical prostatectomy for clinically localized prostate cancer in patients aged 75 years or older: comparison with primary androgen deprivation therapy. The Aging Male 21:1, pages 17-23.
Read now
Read now
Erdem Akbay, Murat Bozlu, Selahittin Çayan, Pelin Özcan Kara, Mesut Tek & Cuma Aytekin. (2017) Prostate-specific antigen decline pattern in advanced prostate cancer receiving androgen deprivation therapy and relationship with prostate-specific antigen progression. The Aging Male 20:3, pages 175-183.
Read now
Read now
Articles from other publishers (6)
Teresa Lam, Vita Birzniece, Mark McLean, Howard Gurney, Amy Hayden & Birinder S. Cheema. (2020) The Adverse Effects of Androgen Deprivation Therapy in Prostate Cancer and the Benefits and Potential Anti-oncogenic Mechanisms of Progressive Resistance Training. Sports Medicine - Open 6:1.
Crossref
Crossref
Birendra Mishra, Gregory W. Lawson, Ryan Ripperdan, Laura Ortiz & Ulrike Luderer. (2018) Charged-Iron-Particles Found in Galactic Cosmic Rays are Potent Inducers of Epithelial Ovarian Tumors. Radiation Research 190:2, pages 142-150.
Crossref
Crossref
Min Ding, Jian-Ying Shi, Yun-Zhi XING, Bei Sun, Qian-Hua Fang, Jing-Yun Zhang, Qiu-Mei Zhang, Li-Ming Chen, De-min Yu & Chun-Jun Li. (2018) Serum adipocyte fatty acid-binding protein levels are associated with peripheral arterial disease in women, but not men, with type 2 diabetes mellitus. Journal of Diabetes 10:6, pages 478-486.
Crossref
Crossref
Cheng‐Qian Zhong, Xiu‐Ping Zhang, Ning Ma, Er‐Bin Zhang, Jing‐Jing Li, Ya‐Bo Jiang, Yu‐Zhen Gao, Yan‐Mei Yuan, Shi‐Qian Lan, Dong Xie & Shu‐Qun Cheng. (2018) FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma. Cancer Medicine 7:6, pages 2629-2640.
Crossref
Crossref
Xiang Hu, Xiaojing Ma, Xiaoping Pan, Yuqi Luo, Yiting Xu, Qin Xiong, Yuqian Bao & Weiping Jia. (2016) Association of androgen with gender difference in serum adipocyte fatty acid binding protein levels. Scientific Reports 6:1.
Crossref
Crossref
Abdulmaged M. Traish & Michael Zitzmann. (2015) The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease. Reviews in Endocrine and Metabolic Disorders 16:3, pages 249-268.
Crossref
Crossref